## AMANDA ROSEWELL SHAW

| | Title| Assistant Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Medicine  
Address| 1102 BATES  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=JKQj5HLCLIfVRIzgrn7GPw%3d%3d&rnd=7617a2af-52b6-40a4-8d4d-fe0a6cd1d923)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=1826695)  
  

Other Positions| Title| Assistant Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Center for Cell & Gene Therapy  
Division| Center for Cell & Gene Therapy  
  
  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Wang D, Porter CE, Lim B, **Rosewell Shaw A** , Robertson CS, [Woods ML](https://profiles.viictr.org/profile/31330385), Xu Y, Biegert GGW, Morita D, Wang T, [Grilley BJ](https://profiles.viictr.org/profile/266987), [Heslop H](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), [Suzuki M](https://profiles.viictr.org/profile/265870). Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies. Sci Adv. 2023 03 29; 9(13):eade6790. PMID: [36989357](//www.ncbi.nlm.nih.gov/pubmed/36989357); PMCID: [PMC10058234](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10058234).

Citations:  Fields:

Sci Science

Translation:AnimalsCells

  2. **Rosewell Shaw A** , Porter C, [Biegert G](https://profiles.viictr.org/profile/31189469), Jatta L, [Suzuki M](https://profiles.viictr.org/profile/265870). HydrAd: A Helper-Dependent Adenovirus Targeting Multiple Immune Pathways for Cancer Immunotherapy. Cancers (Basel). 2022 Jun 02; 14(11). PMID: [35681750](//www.ncbi.nlm.nih.gov/pubmed/35681750); PMCID: [PMC9179443](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9179443).

Citations:

  3. [Biegert GWG](https://profiles.viictr.org/profile/31189469), **Rosewell Shaw A** , [Suzuki M](https://profiles.viictr.org/profile/265870). Current development in adenoviral vectors for cancer immunotherapy. Mol Ther Oncolytics. 2021 Dec 17; 23:571-581. PMID: [34938857](//www.ncbi.nlm.nih.gov/pubmed/34938857); PMCID: [PMC8660697](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8660697).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34938857/citedby/)

  4. **Rosewell Shaw A** , Porter CE, Yip T, Mah WC, [McKenna MK](https://profiles.viictr.org/profile/23496083), [Dysthe M](https://profiles.viictr.org/profile/24845200), Jung Y, [Parihar R](https://profiles.viictr.org/profile/3009684), [Brenner MK](https://profiles.viictr.org/profile/268200), [Suzuki M](https://profiles.viictr.org/profile/265870). Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors. Commun Biol. 2021 03 19; 4(1):368. PMID: [33742099](//www.ncbi.nlm.nih.gov/pubmed/33742099); PMCID: [PMC7979740](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7979740).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33742099/citedby/)
Translation:HumansCells

  5. [Watanabe N](https://profiles.viictr.org/profile/3009961), [McKenna MK](https://profiles.viictr.org/profile/23496083), **Rosewell Shaw A** , [Suzuki M](https://profiles.viictr.org/profile/265870). Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment. Mol Ther. 2021 02 03; 29(2):505-520. PMID: [33130314](//www.ncbi.nlm.nih.gov/pubmed/33130314); PMCID: [PMC7854303](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7854303).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33130314/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  6. Porter CE, **Rosewell Shaw A** , Jung Y, Yip T, [Castro PD](https://profiles.viictr.org/profile/268709), [Sandulache VC](https://profiles.viictr.org/profile/16943294), Sikora A, [Gottschalk S](https://profiles.viictr.org/profile/270181), Ittman MM, [Brenner MK](https://profiles.viictr.org/profile/268200), [Suzuki M](https://profiles.viictr.org/profile/265870). Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors. Mol Ther. 2020 05 06; 28(5):1251-1262. PMID: [32145203](//www.ncbi.nlm.nih.gov/pubmed/32145203); PMCID: [PMC7210703](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7210703).

Citations:
[47](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32145203/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  7. **Rosewell Shaw A** , [Suzuki M](https://profiles.viictr.org/profile/265870). Oncolytic Viruses Partner With T-Cell Therapy for Solid Tumor Treatment. Front Immunol. 2018; 9:2103. PMID: [30298067](//www.ncbi.nlm.nih.gov/pubmed/30298067); PMCID: [PMC6160535](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6160535).

Citations:
[28](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30298067/citedby/) Fields:

All Allergy and Immunology

Translation:HumansAnimalsCells

  8. **Rosewell Shaw A** , Porter CE, [Watanabe N](https://profiles.viictr.org/profile/3009961), Tanoue K, Sikora A, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner MK](https://profiles.viictr.org/profile/268200), [Suzuki M](https://profiles.viictr.org/profile/265870). Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer. Mol Ther. 2017 11 01; 25(11):2440-2451. PMID: [28974431](//www.ncbi.nlm.nih.gov/pubmed/28974431); PMCID: [PMC5675597](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5675597).

Citations:
[77](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28974431/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  9. Tanoue K, **Rosewell Shaw A** , [Watanabe N](https://profiles.viictr.org/profile/3009961), Porter C, Rana B, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner M](https://profiles.viictr.org/profile/268200), [Suzuki M](https://profiles.viictr.org/profile/265870). Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors. Cancer Res. 2017 04 15; 77(8):2040-2051. PMID: [28235763](//www.ncbi.nlm.nih.gov/pubmed/28235763); PMCID: [PMC5392365](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5392365).

Citations:
[97](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28235763/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  10. **Rosewell Shaw A** , [Suzuki M](https://profiles.viictr.org/profile/265870). Recent advances in oncolytic adenovirus therapies for cancer. Curr Opin Virol. 2016 12; 21:9-15. PMID: [27379906](//www.ncbi.nlm.nih.gov/pubmed/27379906); PMCID: [PMC5138135](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5138135).

Citations:
[52](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27379906/citedby/) Fields:

Vir Virology

Translation:Cells

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 10 publications over 7 distinct years, with a maximum of 2
publications in 2017 and 2020 and
2021](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|2&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,50,100,50,0,100,100,50,50,0&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2016| 1  
2017| 2  
2018| 1  
2020| 2  
2021| 2  
2022| 1  
2023| 1  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

ROSEWELL SHAW's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (49)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Oncolytic Virotherapy](https://profiles.viictr.org/profile/243865)
  * [Oncolytic Viruses](https://profiles.viictr.org/profile/250521)
  * [Adenoviridae](https://profiles.viictr.org/profile/253827)
  * [Immunotherapy, Adoptive](https://profiles.viictr.org/profile/250092)
  * [Adoptive Transfer](https://profiles.viictr.org/profile/241720)

[Explore](https://profiles.viictr.org/profile/1826695/198)

_

Co-Authors (13)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [SUZUKI, MASATAKA](https://profiles.viictr.org/profile/265870)
  * [BRENNER, MALCOLM](https://profiles.viictr.org/profile/268200)
  * [Biegert, Greyson](https://profiles.viictr.org/profile/31189469)
  * [WATANABE, NORIHIRO](https://profiles.viictr.org/profile/3009961)
  * [MCKENNA, MARY](https://profiles.viictr.org/profile/23496083)

[Explore](https://profiles.viictr.org/profile/1826695/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [SUZUKI, MASATAKA](https://profiles.viictr.org/profile/265870)
  * [GOTTSCHALK, STEPHEN](https://profiles.viictr.org/profile/270181)
  * [LANG, FREDERICK](https://profiles.viictr.org/profile/265574)
  * [GOMEZ-MANZANO, CANDELARIA](https://profiles.viictr.org/profile/12582553)
  * [BRENNER, MALCOLM](https://profiles.viictr.org/profile/268200)

[Explore](https://profiles.viictr.org/profile/1826695/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [ARMAGHANY, TANNAZ](https://profiles.viictr.org/profile/28999477)
  * [LIN, WEEI-CHIN](https://profiles.viictr.org/profile/266112)
  * [LIU, HAO](https://profiles.viictr.org/profile/265543)
  * [MCKENNA, MARY](https://profiles.viictr.org/profile/23496083)
  * [SEARS, DAVID](https://profiles.viictr.org/profile/267960)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [LIU, KANG](https://profiles.viictr.org/profile/266116)
  * [LULLA, PREMAL](https://profiles.viictr.org/profile/3010220)
  * [MICHAEL, BINU](https://profiles.viictr.org/profile/268573)
  * [OBI, GLORIA](https://profiles.viictr.org/profile/269674)
  * [RIMAWI, MOTHAFFAR](https://profiles.viictr.org/profile/269416)

_

